Prof. Dan Peer and his team are developing a novel gene therapy delivery technology. PYC Therapeutics have been exploring methods for intra Cellular delivery of a range of high value drug cargoes that can’t be covalently linked to its Cell Penetrating Peptides (CPPs). Positive results would open up a whole new world of drug delivery, by overcoming the safety and production concerns associated with delivering these drug cargoes using engineered viruses.

Read PYC Therapeutics, statement here:

 

6